Biotech Funding Gate
Biotech Funding Gate
Market Signal
The master gate for the biotech-capital-cycle lane. The complex re-rates when biotech funding returns. As of 2026-06-04 the gate is HALF-OPEN — issuance is live (2026 IPO wave) but equity appetite isn't (XBI weak-down, fresh deals breaking issue, strength narrow via ARKG). Fires when the appetite leg confirms, which flips the lane from "wait / hold mega-cap-quality laggards" to "rotate into the laggards before they catch up."
Related
9 events DateTypeEvent
May 29 ScanBiotech Scan Jun 16 ScanBiotech Scan Jun 26 ScanBiotech Scan Jul 7 ScanBiotech Scan Apr 28 ScanBiotech Scan Jul 11 ScanBiotech Scan Jul 13 Desk NoteVertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries Apr 26 ScanBiotech Scan Jul 17 ScanBiotech Scan No direct external sources are attached to this read.